# Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy

> **NCT05229874** · PHASE2 · UNKNOWN · sponsor: **Hebei Medical University** · enrollment: 96 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** carbon nanoparticles
- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT05229874
- **Lead sponsor:** Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2023-03-09
- **Final completion:** 2025-01-20
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05229874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05229874, "Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05229874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*